Role of PGE2 in protease-activated receptor-1, -2 and -4 mediated relaxation in the mouse isolated trachea

British Journal of Pharmacology

Volumn 132, Issue 1, 2001, Pages 93-100

  Lan, Rommel S ^a   Knight, Darryl A ^a   Stewart, Geoff A ^a   Henry, Peter J ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Cyclo oxygenase; Indomethacin; Mouse trachea; PARs; Protease activated receptors

Indexed keywords

6 ISOPROPOXY 9 OXO 2 XANTHENECARBOXYLIC ACID; CYCLOOXYGENASE 1 INHIBITOR; INDOMETACIN; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE INHIBITOR; PROSTANOID RECEPTOR; PROSTANOID RECEPTOR ANTAGONIST; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 2; PROTEINASE ACTIVATED RECEPTOR 4; UNCLASSIFIED DRUG; VALERYL SALICYLATE;

AIRWAY DYNAMICS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; DRUG RECEPTOR BINDING; INHIBITION KINETICS; MALE; MOUSE; MUSCLE RELAXATION; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN METABOLISM; PROSTAGLANDIN RELEASE; TRACHEA MUSCLE;

EID: 0035146812     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0703776     Document Type: Article

References (51)

1. Mast cell tryptase stimulates human lung fibroblast proliferation via protease-activated receptor-2
2. Selective inhibition of the cutaneous late but not immediate allergic response to antigens by misoprostol, a PGE analog. Results of a double-blind, placebo-controlled randomized study
3. Expression of cyclo-oxygenase-2 in human airway smooth muscle is associated with profound reductions in cell growth
4. Selective inhibition of prostaglandin endoperoxide synthase-1 (cyclooxygenase-1) by valerylsalicyclic acid
5. Evidence for proteinase-activated receptor-2 (PAR-2)-mediated mitogenesis in coronary artery smooth muscle cells
6. 2 inhibitory effect by the tumor promotor 12.0 tetradecanoyl phorbol-13 acetate
7. 2 on airway smooth muscle in vitro and in vivo
8. 2 mechanism
9. A protective role for protease-activated receptors in the airways
10. Contractile and relaxant actions of prostaglandins on guinea-pig isolated trachea
11. International Union of Pharmacology classification of prostanoid receptors: Properties, distribution, and structure of the receptors and their subtypes
12. Role of the thrombin receptor in development and evidence for a second receptor
13. Cyclooxygenase isoenzyme localization and mRNA expression in rat lungs
14. 2 in cultured guinea pig tracheal smooth muscle cells
15. Identification of potential activators of proteinase-activated receptor-2
16. Cloning and expression of a cDNA for the human prostaglandin E receptor EP1 subtype
17. Characterization of prostanoid relaxant/inhibitory receptors (psi) using a highly selective agonist, TR4979
18. Alpha-Thrombin stimulates contraction of human bronchial rings by activation of protease-activated receptors
19. Protease-activated receptors: PAR4 and counting: How long is the course?
20. Evidence for the presence of a proteinase-activated receptor distinct from the thrombin receptor in vascular endothelial cells
21. Purification and characterization of prostaglandin H synthase-2 from sheep placental cotyledons
22. Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin
23. A dual thrombin receptor system for platelet activation
24. Distribution of postaglandins in human tissues
25. AH6809, a prostaglandin DP-receptor blocking drug on human platelets
26. Studies on the characterisation of prostanoid receptors: A proposed classification
27. Epithelium-derived inhibitory prostaglandins modulate human bronchial smooth muscle responses to histamine
28. Prostaglandin E2, but not prostacyclin inhibits histamine-induced contraction of human bronchial smooth muscle
29. Modulation of airway smooth muscle tone by protease activated receptor-1,-2,-3 and -4 in trachea isolated from influenza A virus-infected mice
30. 2 receptors in relaxation of mouse isolated trachea
31. 2 sensitive (EP)-receptor in the rat isolated trachea
32. B receptor-coupled nitric oxide release in rat aorta
33. Indomethacin suppresses the anti-proliferative effects of transforming growth factor-beta isoforms on fibroblast cell cultures
34. Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor
35. Prostanoid receptors involved in the relaxation of human bronchial preparations
36. The mouse proteinase-activated receptor-2 cDNA and gene. Molecular cloning and functional expression
37. Effect of interleukin-1 beta, tumour necrosis factor-alpha and interferon-gamma on the induction of cyclo-oxygenase-2 in cultured human airway smooth muscle cells
38. 2
39. 2 on allergen-induced asthma
40. 2
41. Selectivity of cyclo-oxygenase inhibitors in human pulmonary epithelial and smooth muscle cells
42. Presence and bronchomotor activity of protease-activated receptor-2 in guinea pig airways
43. Cathepsin G activates protease-activated receptor-4 in human platelets
44. Inhibition of thrombin-induced neuronal cell death by recombinant thrombomodulin and E5510, a synthetic thrombin receptor signaling inhibitor
45. Inhaled misoprostol blocks guinea pig antigen-induced bronchoconstriction and airway inflammation
46. Proteinase-activated receptor-2 in human skin: Tissue distribution and activation of keratinocytes by mast cell tryptase
47. Granzyme A released upon stimulation of cytotoxic T lymphocytes activates the thrombin receptor on neuronal cells and astrocytes
48. Activation of the protease-activated thrombin receptor (PAR)-1 induces motoneuron degeneration in the developing avian embryo
49. Anti-inflammatory drugs and their mechanism of action
50. Expression and localization of COX-2 in human airways and cultured airway epithelial cells
51. 6-Isopropoxy-9-oxoxanthene-2-carboxylic acid (AH 6809), a human EP2 receptor antagonist